XML 54 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Total Terrestrial Energy Inc. Stockholders' Equity (Deficit)
Previously Reported
Total Terrestrial Energy Inc. Stockholders' Equity (Deficit)
Cash issuance
Total Terrestrial Energy Inc. Stockholders' Equity (Deficit)
PIPE Financing
Total Terrestrial Energy Inc. Stockholders' Equity (Deficit)
Preferred Shares
Previously Reported
[1]
Preferred Shares
Retrospective application of recapitalization
[1]
Common Shares
Previously Reported
[1]
Common Shares
Retrospective application of recapitalization
[1]
Common Shares
Cash issuance
Common Shares
PIPE Financing
Common Shares
Preferred Exchangeable Shares
Previously Reported
[1]
Preferred Exchangeable Shares
Retrospective application of recapitalization
[1]
Common Exchangeable Shares
Previously Reported
[1]
Common Exchangeable Shares
Retrospective application of recapitalization
[1]
Exchangeable Shares
Retrospective application of recapitalization
Exchangeable Shares
Additional Paid-In-Capital
Previously Reported
Additional Paid-In-Capital
Retrospective application of recapitalization
Additional Paid-In-Capital
Cash issuance
Additional Paid-In-Capital
PIPE Financing
Additional Paid-In-Capital
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Previously Reported
Accumulated Deficit
Attributable to Non-Controlling Interest
Previously Reported
Attributable to Non-Controlling Interest
Previously Reported
Cash issuance
PIPE Financing
Total
Beginning balance at Dec. 31, 2023 $ (5,410,299)     $ (5,410,299) $ 138 $ (138) $ 675 $ 2,959     $ 3,634 [1] $ 6 $ (6) $ 531 $ (531) $ 2,401 $ 2,401 $ 79,769,519 $ (4,685)     $ 79,764,834 $ (58,336) $ (58,336) $ (85,122,832) $ (85,122,832) $ 534,611 $ 534,611 $ (4,875,688)     $ (4,875,688)
Beginning balance (in shares) at Dec. 31, 2023         137,672 (137,672) 675,281 35,666,101     36,341,382 [1] 6,200 (6,200) 530,924 (530,924) 24,011,017 24,011,017                              
Consolidated Statements of Changes in Stockholders' Equity (Deficit)                                                                
Stock-based compensation       670,243                                   670,243                   670,243
Acquisition of non-controlling interest       534,611             $ 282 [1]                     534,329           $ (534,611)        
Acquisition of non-controlling interest (in shares) [1]                     2,818,520                                          
Issuance of warrants in connection with convertible notes, net of tax       2,006,982                                   2,006,982                   2,006,982
Loss on extinguishment of debt from related parties       (202,204)                                   (202,204)                   (202,204)
Currency translation adjustments       395,525                                       395,525               395,525
Net loss       (11,485,410)                                           (11,485,410)           (11,485,410)
Ending balance at Dec. 31, 2024       (13,490,552)             $ 3,916 [1]           $ 2,401         82,774,184   337,189   (96,608,242)           (13,490,552)
Ending balance (in shares) at Dec. 31, 2024 [2]                     39,159,901 [1]           24,011,017                              
Consolidated Statements of Changes in Stockholders' Equity (Deficit)                                                                
Stock-based compensation                                           180,000                   180,000
Issuance of warrants in connection with convertible notes, net of tax                                           2,595,000                   2,595,000
Net loss                                                   (6,252,000)           (6,252,000)
Ending balance at Mar. 31, 2025                     $ 4,000           $ 2,000         85,549,000   (490,000)   (102,860,000)           (17,795,000)
Ending balance (in shares) at Mar. 31, 2025 [2]                     39,159,901           24,011,017                              
Beginning balance at Dec. 31, 2024       (13,490,552)             $ 3,916 [1]           $ 2,401         82,774,184   337,189   (96,608,242)           (13,490,552)
Beginning balance (in shares) at Dec. 31, 2024 [2]                     39,159,901 [1]           24,011,017                              
Consolidated Statements of Changes in Stockholders' Equity (Deficit)                                                                
Stock-based compensation       3,103,702                                   3,103,702                   3,103,702
Issuance of shares   $ 25,797,201 $ 49,500,000           $ 282 [1] $ 500 [1]                   $ 25,796,919 $ 49,499,500                 $ 25,797,201 $ 49,500,000  
Issuance of shares to PIPE investors [1]                 2,812,708 5,000,000                                            
Issuance of warrants in connection with convertible notes, net of tax       2,594,531                                   2,594,531                   2,594,531
Shares issued upon exercise of warrants       4,500,000             $ 201 [1]                     4,499,799                   4,500,000
Shares issued upon exercise of warrants (in shares) [1]                     2,011,632                                          
Shares issued upon exercise of options       136             $ 7 [1]                     129                   $ 136
Shares issued upon exercise of options (in shares)                     67,054 [1]                                         67,054
Merger financing       243,066,977             $ 2,874 [1]                     243,064,103                   $ 243,066,977
Merger financing (in shares) [1]                     28,742,610                                          
Transaction costs       (22,305,729)                                   (22,305,729)                   (22,305,729)
Conversion of convertible notes to Common Shares       29,787,900             $ 397 [1]                     29,787,503                   29,787,900
Conversion of convertible notes to Common Shares (in shares) [1]                     3,977,517                                          
Currency translation adjustments       (260,731)                                       (260,731)               (260,731)
Change in unrealized gains on short term investments       1,129,448                                       1,129,448               1,129,448
Net loss       (28,016,641)                                           (28,016,641)           (28,016,641)
Ending balance at Dec. 31, 2025       $ 295,406,242             $ 8,177 [1]           $ 2,401         418,814,641   1,205,906   (124,624,883)           295,406,242
Ending balance (in shares) at Dec. 31, 2025                     81,771,422 [1]           24,011,017                              
Consolidated Statements of Changes in Stockholders' Equity (Deficit)                                                                
Stock-based compensation                                           2,761,000                   2,761,000
Issuance of shares to PIPE investors                     12,000                                          
Shares issued upon exercise of options                                           158,000                   158,000
Shares issued upon exercise of options (in shares)                     140,815           (318,197)                              
Net loss                                                   (10,503,000)           (10,503,000)
Ending balance at Mar. 31, 2026                     $ 8,000           $ 2,000         $ 421,734,000   $ 1,980,000   $ (135,128,000)           $ 288,596,000
Ending balance (in shares) at Mar. 31, 2026                     82,242,434           23,692,820                              
[1] Share amounts have been retroactively restated to give effect to the Business Combination.
[2] The shares of the Company’s common stock prior to the Recapitalization have been retrospectively recast to reflect the change in the capital structure as a result of the Recapitalization as described in Note 1.